73 research outputs found

    Nucleoside/nucleotide reverse transcriptase inhibitor sparing regimen with once daily integrase inhibitor plus boosted darunavir is non-inferior to standard of care in virologically-suppressed children and adolescents living with HIV – Week 48 results of the randomised SMILE Penta-17-ANRS 152 clinical trial

    Get PDF

    Mamma-Carcinom und Cortison

    Full text link

    Surgical Treatment and Prognosis in Colorectal Cancer. Report on 1357 Cases

    Full text link
    corecore